Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Screening older adults in Singapore for frailty and early health decline

Recruiting · Sengkang General Hospital

What this means

This trial plans to screen older adults for frailty and loss of physical and mental ability. It will compare people who get care right away with people who wait a year. The trial has not reported results yet, so we do not know if it helps.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 60 and over
Where
1 site

Contacts and how to join ↗

The science

Registered title
Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore
Phase
Not applicable
Study type
interventional
Conditions
Frailty in Older Adults, Intrinsic Capacity, Age-related Functional Decline, Healthy Ageing
What is tested
INFINITY-ICOPE programme
Sponsor
Sengkang General Hospital
Ages
60 Years to no maximum
Dates
First posted Mar 17, 2026 · updated Apr 17, 2026

Registry summary

The goal of this intervention study is to screen and identify frailty and decline in intrinsic capacity (physical and mental capacities) in community-dwelling older adults in Singapore, and to evaluate whether early identification and targeted interventions can improve health outcomes and support healthy ageing. The main questions it aims to answer are:

  • Can combined frailty and intrinsic capacity screening with targeted interventions prevent or reduce functional decline in older adults, as measured by changes in life space mobility?
  • Will at least 80% of screened older adults adhere to recommended care pathways and interventions?
  • Can this screening and intervention programme demonstrate sustainability through continued community participation and recruitment of new partner organizations beyond the initial implementation phase? The investigators will compare an intervention group (receiving immediate assessment and clinical referrals based on identified needs) to a wait-list control group (receiving the same interventions 12 months later) to see if early intervention leads to better health outcomes and quality of life.

Participants will:

  • Attend 4 study visits over 2 years (at 6-monthly intervals in the first year, with final assessment at end of year 2), each lasting up to 2 hours.
  • Undergo comprehensive screening assessments including mobility, cognition, mental health, hearing, vision, and nutritional status.
  • Receive 2 follow-up phone calls at 3-month and 9-month intervals to monitor progress.
  • If in the intervention group: receive personalized referrals for further care (which may include comprehensive geriatric assessment, primary care reviews, rehabilitation, or dietitian consultations) and guidance on using a mobile health monitoring application.
  • If in the wait-list control group: receive the same interventions after their 3rd study visit (12 months later).

Sites (1)

  • Sengkang General Hospital, Singapore, Singapore
Report a problem